Endologix develops, manufactures, markets, and sells medical devices for the treatment of aortic disorders. Co.'s products are designed for the endovascular treatment of abdominal aortic aneurysms (AAA). The AAA products are built on one of two platforms: endovascular aneurysm repair (EVAR); or endovascular aneurysm sealing (EVAS), Co.'s solution for sealing the aneurysm sac while maintaining blood flow. Co.'s EVAR products include the AFX® Endovascular AAA System, the VELA® Proximal Endograft, and the Ovation® Abdominal Stent Graft System. Co.'s EVAS product is the Nellix® Endovascular Aneurysm Sealing System. We show 46 historical shares outstanding datapoints in our ELGX shares outstanding history coverage, used to compute ELGX market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ELGX market cap history over the course of time is important for investors
interested in comparing ELGX's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ELGX versus a peer is one thing; comparing
ELGX market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ELGX can fluctuate over the course of history.
With this page we aim to empower investors researching ELGX by allowing them to research the ELGX market cap history. |
Free ELGX Email Alerts:
Video: The Importance of Market Cap
